Vitamin D May Influence Patients’ Response to Treatment, Risk of Remission

Vitamin D May Influence Patients’ Response to Treatment, Risk of Remission
Vitamin D levels may influence response to treatment with anti-TNFα medications in patients with inflammatory bowel disease (IBD), according to new research that also linked low vitamin D to reduced risk of IBD remission. The research paper, “Higher 25-hydroxyvitamin D Levels Are Associated With Greater Odds Of Remission With Anti-Tumour Necrosis Factor-A Medications Among Patients

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

4 comments

    • Tim Bossie says:

      The study does not go into the levels, but a level of 20 nanograms/milliliter to 50 ng/mL is considered adequate. A level less than 12 ng/mL indicates vitamin D deficiency.

  1. mathix says:

    “Patients with lower vitamin D levels had lower risk of remission”
    Risk of remission or risk of relapse? This changes everything.

Leave a Comment

Your email address will not be published. Required fields are marked *